Global Silymarin Market Growth 2023-2029

Global Silymarin Market Growth 2023-2029

Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
LPI (LP Information)' newest research report, the “Silymarin Industry Forecast” looks at past sales and reviews total world Silymarin sales in 2022, providing a comprehensive analysis by region and market sector of projected Silymarin sales for 2023 through 2029. With Silymarin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Silymarin industry.
This Insight Report provides a comprehensive analysis of the global Silymarin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Silymarin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Silymarin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Silymarin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Silymarin.
The global Silymarin market size is projected to grow from US$ 88 million in 2022 to US$ 110.7 million in 2029; it is expected to grow at a CAGR of 110.7 from 2023 to 2029.
The top players cover LIVERD PHARMA, TY Pharmaceutical, KEB Biotech, etc. The Top 3 players in Global Silymarin market revenue was 50.46% in 2019, while the share of top 5 players was 61.99%. TY Pharmaceutical is the leading supplier of Silymarin, the production of which reached 438 MT in 2019, accounting for about 18.81% of the Global market. Market concentration is high. Except policy affect, downstream demand is the key influence factor to the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Silymarin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Silymarin Extracted by Acetone
Silymarin Extracted by Ethyl Acetate
Silymarin Extracted by Ethanol
Water Soluble Silymarin
Segmentation by application
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb

Key Questions Addressed in this Report
What is the 10-year outlook for the global Silymarin market?
What factors are driving Silymarin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Silymarin market opportunities vary by end market size?
How does Silymarin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.